F

Ford Motor Company

52
Fundamentals40/ 100
Valuation50/ 100
Upside potential57/ 100
Risk potential23/ 100

F has a slight edge over MNRO overall, supported by lower modeled downside.

MNRO

Monro, Inc.

50
Fundamentals54/ 100
Valuation50/ 100
Upside potential60/ 100
Risk potential34/ 100

MNRO offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.

F Fundamentals

MetricStatus
Stable
Under pressure
Under pressure
Strong

F's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.

MNRO Fundamentals

MetricStatus
Stable
Stable
Under pressure
Healthy

MNRO's balance sheet is currently healthy, and its revenue and profitability are stable, but its cash flow is under pressure.

F PE Valuation

F has no meaningful PE right now: it lost money over the past year.

MNRO PE Valuation

MNRO has no meaningful PE right now: it lost money over the past year.

F Forward outlook

MetricOutlook
--
Strong growth
Stable
Improving
Limited
Low

F has the edge over MNRO on the outlook, with more favorable earnings and profitability expectations.

MNRO Forward outlook

MetricOutlook
--
Turning to a loss
Stable
Weakening
Limited
High

Analysts expect MNRO's earnings and profitability to decline, with its revenue holding steady.

F Risk to reward

ScenarioChangePrice
Upside+31%$15.58
Downside-23%$9.16

Calculated from the latest close: $11.90 on Nov 12.

F trails MNRO on modeled risk to reward, with less potential upside relative to its potential downside.

MNRO Risk to reward

ScenarioChangePrice
Upside+50%$15.51
Downside-34%$6.88

Calculated from the latest close: $10.36 on Nov 12.

MNRO has a better modeled risk to reward balance than F, with more potential upside relative to its potential downside.

F Earnings Per Share

Q4 2023: $1.08Q1 2024: $0.97Q2 2024: $0.96Q3 2024: $0.88Q4 2024: $1.46Q1 2025: $1.25Q2 2025: $0.78Q3 2025: $1.16Q4 2025: $-2.06Q1 2026: $-1.55Q2 2026: $-1.87Q3 2026: $-1.97Forward: $1.78
Q4 2023: $1.08Q1 2024: $0.97Q2 2024: $0.96Q3 2024: $0.88Q4 2024: $1.46Q1 2025: $1.25Q2 2025: $0.78Q3 2025: $1.16Q4 2025: $-2.06Q1 2026: $-1.55Q2 2026: $-1.87Q3 2026: $-1.97Forward: $1.78
QuarterTTM EPSYoY
Forward$1.78—
Q3 2026-$1.97-270%
Q2 2026-$1.87-340%
Q1 2026-$1.55-224%
Q4 2025-$2.06-241%
Q3 2025$1.16+32%
Q2 2025$0.78-19%
Q1 2025$1.25+29%
Q4 2024$1.46+35%

F has swung to a loss: it lost $1.97 per share over the past year, after a profit the year before.

MNRO Earnings Per Share

Q4 2023: $1.08Q1 2024: $1.18Q2 2024: $1.09Q3 2024: $0.87Q4 2024: $0.64Q1 2025: $-0.22Q2 2025: $-0.69Q3 2025: $-0.69Q4 2025: $-0.49Q1 2026: $0.03Q2 2026: $0.23Q3 2026: $0.00
Q4 2023: $1.08Q1 2024: $1.18Q2 2024: $1.09Q3 2024: $0.87Q4 2024: $0.64Q1 2025: $-0.22Q2 2025: $-0.69Q3 2025: $-0.69Q4 2025: $-0.49Q1 2026: $0.03Q2 2026: $0.23Q3 2026: $0.00
QuarterTTM EPSYoY
Q3 2026$0.00+$0.69
Q2 2026$0.23+$0.92
Q1 2026$0.03+$0.25
Q4 2025-$0.49-177%
Q3 2025-$0.69-179%
Q2 2025-$0.69-163%
Q1 2025-$0.22-119%
Q4 2024$0.64-41%

MNRO is still losing money, but far less than before: $0.00 per share over the past year, against $0.69 at its worst in mid-2025.

F Quarterly Revenue

Q4 2023: $46BQ1 2024: $42.8BQ2 2024: $47.8BQ3 2024: $46.2BQ4 2024: $48.2BQ1 2025: $40.7BQ2 2025: $50.2BQ3 2025: $50.5BQ4 2025: $45.9BQ1 2026: $43.3BQ2 2026: $48.3BQ3 2026: $49.5B
Q4 2023: $46BQ1 2024: $42.8BQ2 2024: $47.8BQ3 2024: $46.2BQ4 2024: $48.2BQ1 2025: $40.7BQ2 2025: $50.2BQ3 2025: $50.5BQ4 2025: $45.9BQ1 2026: $43.3BQ2 2026: $48.3BQ3 2026: $49.5B
QuarterRevenueYoY
Q3 2026$49.5B-2%
Q2 2026$48.3B-3.8%
Q1 2026$43.3B+6.4%
Q4 2025$45.9B-4.8%
Q3 2025$50.5B+9.4%
Q2 2025$50.2B+5%
Q1 2025$40.7B-5%
Q4 2024$48.2B+4.9%

F has the edge over MNRO on sales, with more consistent year-over-year improvement.

MNRO Quarterly Revenue

Q4 2023: $318MQ1 2024: $310MQ2 2024: $293MQ3 2024: $301MQ4 2024: $306MQ1 2025: $295MQ2 2025: $301MQ3 2025: $289MQ4 2025: $293MQ1 2026: $274MQ2 2026: $287MQ3 2026: $284M
Q4 2023: $318MQ1 2024: $310MQ2 2024: $293MQ3 2024: $301MQ4 2024: $306MQ1 2025: $295MQ2 2025: $301MQ3 2025: $289MQ4 2025: $293MQ1 2026: $274MQ2 2026: $287MQ3 2026: $284M
QuarterRevenueYoY
Q3 2026$283.6M-1.8%
Q2 2026$287.1M-4.6%
Q1 2026$273.8M-7.2%
Q4 2025$293.4M-4%
Q3 2025$288.9M-4.1%
Q2 2025$301M+2.7%
Q1 2025$295M-4.9%
Q4 2024$305.8M-3.7%

MNRO's revenue has slid since its 2022 peak: $284M last quarter, down 1.8% from the same quarter a year ago.

F Free Cash Flow

Q4 2023: $197MQ1 2024: −$709MQ2 2024: $3.4BQ3 2024: $3.5BQ4 2024: $530MQ1 2025: $1.9BQ2 2025: $4.2BQ3 2025: $5.3BQ4 2025: $1.1BQ1 2026: −$1.1BQ2 2026: $2BQ3 2026: $3.1B
Q4 2023: $197MQ1 2024: −$709MQ2 2024: $3.4BQ3 2024: $3.5BQ4 2024: $530MQ1 2025: $1.9BQ2 2025: $4.2BQ3 2025: $5.3BQ4 2025: $1.1BQ1 2026: −$1.1BQ2 2026: $2BQ3 2026: $3.1B
QuarterFree cash flowYoY
Q3 2026$3.1B-40%
Q2 2026$2B-54%
Q1 2026-$1.1B-157%
Q4 2025$1.1B+108%
Q3 2025$5.3B+50%
Q2 2025$4.2B+24%
Q1 2025$1.9B+$2.6B
Q4 2024$530M+169%

F has the edge over MNRO on cash flow, with more consistent year-over-year improvement.

MNRO Free Cash Flow

Q4 2023: $29MQ1 2024: −$12MQ2 2024: $17MQ3 2024: $58MQ4 2024: $8MQ1 2025: $23MQ2 2025: −$9MQ3 2025: $27MQ4 2025: $9MQ1 2026: $12MQ2 2026: −$38MQ3 2026: $29M
Q4 2023: $29MQ1 2024: −$12MQ2 2024: $17MQ3 2024: $58MQ4 2024: $8MQ1 2025: $23MQ2 2025: −$9MQ3 2025: $27MQ4 2025: $9MQ1 2026: $12MQ2 2026: −$38MQ3 2026: $29M
QuarterFree cash flowYoY
Q3 2026$28.8M+8.2%
Q2 2026-$37.9M-$28.6M
Q1 2026$12.4M-47%
Q4 2025$9.1M+15%
Q3 2025$26.6M-54%
Q2 2025-$9.3M-156%
Q1 2025$23.2M+$35.1M
Q4 2024$7.9M-73%

MNRO still generates free cash flow, though less than at its 2022 peak: $12M over the past year.

F Total Shares

Q4 2023: 4BQ1 2024: 4BQ2 2024: 4BQ3 2024: 4BQ4 2024: 4BQ1 2025: 4BQ2 2025: 4BQ3 2025: 4BQ4 2025: 4BQ1 2026: 4.1BQ2 2026: 4BQ3 2026: 4.1B
Q4 2023: 4BQ1 2024: 4BQ2 2024: 4BQ3 2024: 4BQ4 2024: 4BQ1 2025: 4BQ2 2025: 4BQ3 2025: 4BQ4 2025: 4BQ1 2026: 4.1BQ2 2026: 4BQ3 2026: 4.1B
PeriodChange %Net change
Quarterly+2.2%+89M shares
1 year+0.7%+28M shares
3 years+0.6%+26M shares
5 years+1%+40M shares
Available history+1.8%+72M shares

F has 4.1B diluted shares, up 0.7% from a year ago.

MNRO Total Shares

Q4 2023: 32MQ1 2024: 32MQ2 2024: 31MQ3 2024: 31MQ4 2024: 31MQ1 2025: 30MQ2 2025: 30MQ3 2025: 31MQ4 2025: 31MQ1 2026: 30MQ2 2026: 30MQ3 2026: 31M
Q4 2023: 32MQ1 2024: 32MQ2 2024: 31MQ3 2024: 31MQ4 2024: 31MQ1 2025: 30MQ2 2025: 30MQ3 2025: 31MQ4 2025: 31MQ1 2026: 30MQ2 2026: 30MQ3 2026: 31M
PeriodChange %Net change
Quarterly+3.8%+1.1M shares
1 year-0.2%-68K shares
3 years-3%-977K shares
5 years-8%-2.7M shares
Available history-7.9%-2.7M shares

MNRO has the edge over F on shareholder dilution, with a more favorable share count trend.

F Net Leverage

Q4 2023: -1.9xQ1 2024: -1.6xQ2 2024: -1.7xQ3 2024: -2.1xQ4 2024: -1.8xQ1 2025: -1.8xQ2 2025: -2.2xQ3 2025: -2.4xQ4 2025: -3.4xQ1 2026: -2.0xQ2 2026: -2.1xQ3 2026: -2.5x
Q4 2023: -1.9xQ1 2024: -1.6xQ2 2024: -1.7xQ3 2024: -2.1xQ4 2024: -1.8xQ1 2025: -1.8xQ2 2025: -2.2xQ3 2025: -2.4xQ4 2025: -3.4xQ1 2026: -2.0xQ2 2026: -2.1xQ3 2026: -2.5x
QuarterNet LeverageStatus
Q3 2026-2.5xNet Cash
Q2 2026-2.1xNet Cash
Q1 2026-2.0xNet Cash
Q4 2025-3.4xNet Cash
Q3 2025-2.4xNet Cash
Q2 2025-2.2xNet Cash
Q1 2025-1.8xNet Cash
Q4 2024-1.8xNet Cash

F has the edge over MNRO on leverage, with a lower net debt burden relative to earnings.

MNRO Net Leverage

Q4 2023: 0.8xQ1 2024: 0.9xQ2 2024: 1.0xQ3 2024: 0.6xQ4 2024: 0.8xQ1 2025: 1.0xQ2 2025: 1.7xQ3 2025: 1.5xQ4 2025: 1.2xQ1 2026: 1.0xQ2 2026: 1.5xQ3 2026: 1.5x
Q4 2023: 0.8xQ1 2024: 0.9xQ2 2024: 1.0xQ3 2024: 0.6xQ4 2024: 0.8xQ1 2025: 1.0xQ2 2025: 1.7xQ3 2025: 1.5xQ4 2025: 1.2xQ1 2026: 1.0xQ2 2026: 1.5xQ3 2026: 1.5x
QuarterNet LeverageStatus
Q3 20261.5xHealthy
Q2 20261.5xHealthy
Q1 20261.0xHealthy
Q4 20251.2xHealthy
Q3 20251.5xHealthy
Q2 20251.7xHealthy
Q1 20251.0xVery low
Q4 20240.8xVery low

MNRO's net debt is about 1.5 years of its operating earnings (EBITDA), about the same as a year ago.

F Weekly Momentum

MetricValueStatus
RSI41.5Neutral
Stochastic19.6Oversold

F's weekly RSI is 41 (neutral) and its Stochastic is 20 (oversold).

MNRO Weekly Momentum

MetricValueStatus
RSI34.0Neutral
Stochastic5.4Oversold

MNRO's weekly RSI is 34 (neutral) and its Stochastic is 5 (oversold).

F PE vs Consumer Cyclical Sector

MetricFSector medianRelative
PEN/A18x—

F has no meaningful PE right now: it lost money over the past year.

MNRO PE vs Consumer Cyclical Sector

MetricMNROSector medianRelative
PE58x18x219% above
PE %854738 pts above

MNRO has no meaningful PE right now: it lost money over the past year.

F Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$12.22.5% below
20 week MA$13.311% below
50 week MA$13.411% below
100 week MA$12.12% below
200 week MA$12.11.4% below

F is in a downtrend: it's below all five of its weekly moving averages, and 1.4% below its 200-week average.

MNRO Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$12.718% below
20 week MA$13.523% below
50 week MA$16.437% below
100 week MA$16.838% below
200 week MA$25.159% below

MNRO is in a downtrend: it's below all five of its weekly moving averages, and 59% below its 200-week average.

F Yearly ROI

YearStart priceEnd priceROI
2020$9.36$8.86-5.3%
2021$8.86$20.3+129%
2022$20.3$11.4-44%
2023$11.4$12.2+7.3%
2024$12.2$10.0-18%
2025$10.0$13.3+33%
2026 YTD$13.3$11.9-11%

F has the edge over MNRO on returns for 2026, with the stronger performance.

MNRO Yearly ROI

YearStart priceEnd priceROI
2020$78.9$53.1-33%
2021$53.1$59.2+11%
2022$59.2$45.2-24%
2023$45.2$29.3-35%
2024$29.3$24.8-16%
2025$24.8$20.8-16%
2026 YTD$20.8$10.4-50%

MNRO has finished four years in a row lower, and it's down 50% so far in 2026.

Give your agent the market.

Get API key